Robert Klamroth Selected Research

Robert Klamroth Research Topics

Disease

30	Hemophilia A (Haemophilia) 03/2022 - 04/2009
24	Hemorrhage 03/2022 - 01/2007
8	Thrombosis (Thrombus) 01/2022 - 03/2008
5	Thrombocytopenia (Thrombopenia) 06/2021 - 01/2007
4	COVID-19 06/2021 - 06/2020
4	Hemophilia B (Haemophilia B) 01/2021 - 09/2012
3	von Willebrand Diseases (von Willebrand's Disease) 05/2014 - 01/2007
2	Neoplasms (Cancer) 01/2022 - 01/2019
2	Thrombotic Microangiopathies 05/2021 - 12/2020
2	Thrombophilia 01/2013 - 08/2012
2	Body Weight (Weight, Body) 08/2010 - 01/2007
1	Venous Thrombosis (Deep-Vein Thrombosis) 01/2022
1	Hematoma 06/2021
1	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 06/2021
1	Metrorrhagia (Spotting) 05/2021
1	Venous Thromboembolism 01/2019
1	Vomiting 01/2019
1	Necrosis 11/2017
1	Type 1 von Willebrand Disease 08/2013
1	Type 2 von Willebrand Disease 08/2013
1	Fistula 01/2013
1	Disseminated Intravascular Coagulation 01/2007
1	Disease Susceptibility (Diathesis) 01/2007
1	Factor VII Deficiency (Hypoproconvertinemia) 01/2007
1	Habitual Abortion (Recurrent Miscarriage) 05/2005
1	Obesity 05/2005

Drug/Important Bio-Agent (IBA)

21	Factor VIII (Coagulation Factor VIII)IBA 06/2021 - 04/2009
6	emicizumabIBA 03/2022 - 08/2017
6	AnticoagulantsIBA 01/2022 - 08/2012
5	Hemostatics (Antihemorrhagics)IBA 02/2022 - 02/2015
4	AntibodiesIBA 03/2022 - 05/2005
4	recombinant factor VIII N8IBA 02/2022 - 01/2020
4	Factor IX (Coagulation Factor IX)FDA LinkGeneric 06/2021 - 09/2012
4	Heparin (Liquaemin)FDA LinkGeneric 06/2021 - 03/2008
4	Proteins (Proteins, Gene)FDA Link 01/2021 - 08/2012
3	Blood Coagulation Factors (Coagulation Factor)IBA 03/2022 - 01/2007
3	VaccinesIBA 06/2021 - 06/2021
3	Prothrombin (Factor II)IBA 05/2021 - 05/2005
3	AutoantibodiesIBA 01/2020 - 04/2009
3	AntithrombinsIBA 08/2012 - 05/2005
2	BAX 855IBA 01/2021 - 01/2019
2	factor IX Fc fusion proteinIBA 01/2021 - 04/2019
2	AlbuminsIBA 01/2021 - 09/2012
2	factor VIII-Fc fusion proteinIBA 01/2021 - 01/2016
2	BAY 94-9027IBA 01/2021 - 01/2019
2	6-pyruvoyltetrahydropterin synthase (PTPS)IBA 01/2020 - 01/2019
2	Serum AlbuminIBA 01/2019 - 05/2013
2	Factor IXa (Coagulation Factor IXa)IBA 01/2019 - 08/2017
2	Fondaparinux (Arixtra)FDA Link 11/2017 - 07/2014
2	von Willebrand FactorIBA 08/2013 - 08/2013
2	Protein SIBA 08/2012 - 05/2005
2	Protein CIBA 08/2012 - 05/2005
1	COVID-19 VaccinesIBA 06/2021
1	ChAdOx1 nCoV-19IBA 06/2021
1	Indicators and Reagents (Reagents)IBA 01/2021
1	prothrombin complex concentrates (PPSB)IBA 01/2020
1	nonacog beta pegolIBA 04/2019
1	Vitamin K FDA Link 01/2019
1	N(4)-oleylcytosine arabinosideIBA 01/2019
1	simoctocog alfa (Nuwiq)IBA 01/2019
1	Coenzymes (Enzyme Cofactors)IBA 01/2019
1	CoagulantsIBA 01/2019
1	LigandsIBA 01/2019
1	Thrombin FDA Link 01/2019
1	lepirudin (Refludan)FDA Link 11/2017
1	argatroban (MPQA)FDA Link 11/2017
1	danaparoid (Orgaran)FDA Link 11/2017
1	Immunoglobulin G (IgG)IBA 08/2017
1	Factor X (Stuart Factor)IBA 08/2017
1	Neutralizing AntibodiesIBA 09/2013
1	Polytetrafluoroethylene (Teflon)FDA Link 01/2013
1	Human Serum Albumin FDA LinkGeneric 09/2012
1	Recombinant Fusion ProteinsIBA 09/2012
1	Phenprocoumon (Liquamar)FDA Link 08/2010
1	Enoxaparin (Lovenox)FDA LinkGeneric 08/2010
1	SteroidsIBA 04/2009
1	Rituximab (Mabthera)FDA Link 04/2009
1	Pharmaceutical PreparationsIBA 01/2007
1	recombinant FVIIa (rFVIIa)FDA Link 01/2007
1	Plasminogen InactivatorsIBA 05/2005
1	Factor V (Coagulation Factor V)IBA 05/2005
1	Lipoprotein(a)IBA 05/2005

Therapy/Procedure

10	Therapeutics 03/2022 - 01/2007
2	Injections 05/2019 - 01/2007
1	Secondary Prevention 01/2022
1	Radiotherapy 01/2022
1	Intramuscular Injections 06/2021
1	Blood Transfusion (Blood Transfusions) 01/2021
1	Surgical Amputation (Amputations) 11/2017
1	Intravenous Injections 08/2017
1	Replacement Arthroplasty 11/2014
1	Cholecystectomy 11/2014
1	Off-Label Use 07/2014
1	Renal Dialysis (Hemodialysis) 01/2013